These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 18678689)
1. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Thomas CP; Reif S; Haq S; Wallack SS; Hoyt A; Ritter GA Psychiatr Serv; 2008 Aug; 59(8):909-16. PubMed ID: 18678689 [TBL] [Abstract][Full Text] [Related]
2. Buprenorphine for office-based practice: consensus conference overview. Kosten TR; Fiellin DA; Am J Addict; 2004; 13 Suppl 1():S1-7. PubMed ID: 15204671 [TBL] [Abstract][Full Text] [Related]
3. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Suzuki J; Connery HS; Ellison TV; Renner JA Am J Addict; 2014; 23(6):618-22. PubMed ID: 25065457 [TBL] [Abstract][Full Text] [Related]
4. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Jones CM; McCance-Katz EF Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876 [TBL] [Abstract][Full Text] [Related]
5. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Walley AY; Alperen JK; Cheng DM; Botticelli M; Castro-Donlan C; Samet JH; Alford DP J Gen Intern Med; 2008 Sep; 23(9):1393-8. PubMed ID: 18592319 [TBL] [Abstract][Full Text] [Related]
6. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Rosenblatt RA; Andrilla CH; Catlin M; Larson EH Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888 [TBL] [Abstract][Full Text] [Related]
7. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. Kissin W; McLeod C; Sonnefeld J; Stanton A J Addict Dis; 2006; 25(4):91-103. PubMed ID: 17088229 [TBL] [Abstract][Full Text] [Related]
8. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434 [TBL] [Abstract][Full Text] [Related]
9. Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio. Molfenter T; Sherbeck C; Zehner M; Quanbeck A; McCarty D; Kim JS; Starr S Subst Abuse Treat Prev Policy; 2015 Mar; 10():13. PubMed ID: 25884206 [TBL] [Abstract][Full Text] [Related]
10. Bupreorphine:a new pharmacotherapy for opioid addictions treatment. Stock C; Shum JH J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630 [TBL] [Abstract][Full Text] [Related]
11. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program. Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802 [TBL] [Abstract][Full Text] [Related]
14. Challenges in increasing access to buprenorphine treatment for opiate addiction. West JC; Kosten TR; Wilk J; Svikis D; Triffleman E; Rae DS; Narrow WE; Duffy FF; Regier DA Am J Addict; 2004; 13 Suppl 1():S8-16. PubMed ID: 15204672 [TBL] [Abstract][Full Text] [Related]
15. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial. Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653 [TBL] [Abstract][Full Text] [Related]
16. Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment. Knudsen HK; Studts JL J Behav Health Serv Res; 2019 Jan; 46(1):151-163. PubMed ID: 30069622 [TBL] [Abstract][Full Text] [Related]
17. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors. Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136 [TBL] [Abstract][Full Text] [Related]
18. Barriers to primary care physicians prescribing buprenorphine. Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308 [TBL] [Abstract][Full Text] [Related]
19. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Cunningham CO; Sohler NL; McCoy K; Kunins HV Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients. Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]